Cover Image

Discovery of biomarkers in the era of radioimmunotherapy against lung cancer: A bench‐to‐bedside promise

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Anni Wang, Siyu Wang, Shijie Zhang, Fuliang Liu, Tianle Zhou, Zhengqian Li, Yixue Wang, Jingxue Xu, Jing Cai, Xiaoyuan Wang, Hang Yin
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	International Journal of Cancer
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prospects for radioimmunotherapy panaceas in gynecologic oncology
by: Charles A. Kunos, et al.
Published: (2025)

RBBP4: A novel diagnostic and prognostic biomarker for non‐small‐cell lung cancer correlated with autophagic cell death
by: Yajing Zhan, et al.
Published: (2024)

Prediction performance comparison of biomarkers for response to immune checkpoint inhibitors in advanced non‐small cell lung cancer
by: Jie Zhao, et al.
Published: (2024)

Salivary metabolomic biomarkers for non‐invasive lung cancer detection
by: Naohiro Kajiwara, et al.
Published: (2024)

KIFC3 promotes the progression of non–small cell lung cancer cells through the PI3K/Akt pathway
by: Yu Mu, et al.
Published: (2024)

TRIP13: A promising cancer immunotherapy target
by: Shengnan Jing, et al.
Published: (2024)

ILT4 facilitates angiogenesis in non‐small cell lung cancer
by: Shuyun Wang, et al.
Published: (2024)

Homologous recombination deficiency status predicts response to immunotherapy‐based treatment in non‐small cell lung cancer patients
by: Ai Gao, et al.
Published: (2024)

ACAT2 may be a novel predictive biomarker and therapeutic target in lung adenocarcinoma
by: Zhongchao Wang, et al.
Published: (2024)

Immune checkpoint inhibitors combined with anti‐angiogenic therapy as second‐ or further‐line treatment for small cell lung cancer: Efficacy, safety, and prognostic biomarkers
by: Tong Chen, et al.
Published: (2025)

Multiple primary lung cancer: Updates and perspectives
by: Ziqi Wang, et al.
Published: (2024)

Overall survival according to time‐of‐day of immunochemotherapy for extensive‐stage small cell lung cancer
by: Zhe Huang, et al.
Published: (2025)

Immunogenic cell death: A promising mechanism involving different therapeutic strategies for liver cancer
by: Ziye Yang, et al.
Published: (2025)

Using MRI radiomics to predict the efficacy of immunotherapy for brain metastasis in patients with small cell lung cancer
by: Xiaonan Shi, et al.
Published: (2024)

Genomic heterogeneity of multiple synchronous lung cancers in Chinese population
by: Lei Zhao, et al.
Published: (2024)

The current therapeutic cancer vaccines landscape in non‐small cell lung cancer
by: Shaoyi Chen, et al.
Published: (2024)

A local perspective on internal, external, and reflexive biomarker testing processes for lung cancer in an academic medical center
by: Andrea M. Russell, et al.
Published: (2024)

A targeting nanoplatform for chemo‐photothermal synergistic therapy of small‐cell lung cancer
by: Moli Yin, et al.
Published: (2024)

Methyltransferase like‐14 suppresses growth and metastasis of non‐small‐cell lung cancer by decreasing LINC02747
by: Jiemin Wang, et al.
Published: (2024)

New AI model shows promise for cancer diagnosis
by: Mary Beth Nierengarten
Published: (2025)

Lipocalin‐2 as a prognostic biomarker and its association with systemic inflammation in small cell lung cancer
by: Se‐Il Go, et al.
Published: (2024)

Craniospinal irradiation and/or intraventricular radioimmunotherapy after high‐dose chemotherapy and autologous stem cell rescue in patients with CNS retinoblastoma—Safety and outcomes
by: Sameer Farouk Sait, et al.
Published: (2024)

Global burden of lung cancer in women of childbearing age attributable to ambient particulate matter pollution: 1990–2021
by: Ying‐da Song, et al.
Published: (2024)

Risk Factors for Financial Toxicity in Patients With Pancreatic Cancer
by: Jing Wang, et al.
Published: (2025)

Acute hospitalizations after proton therapy versus intensity‐modulated radiotherapy for locally advanced non–small cell lung cancer in the durvalumab era
by: Michelle Iocolano, et al.
Published: (2024)

Schizandrin A induces non‐small cell lung cancer apoptosis by suppressing the epidermal growth factor receptor activation
by: Linhai Zhu, et al.
Published: (2024)

Safety and efficacy evaluation of personalized exercise prescription during chemotherapy for lung cancer patients
by: Qian Li, et al.
Published: (2024)

Cost‐effectiveness analysis of osimertinib plus chemotherapy for patients with EGFR‐mutated advanced non‐small cell lung cancer
by: Wentao Tian, et al.
Published: (2024)

Artificial intelligence in lung cancer screening: Detection, classification, prediction, and prognosis
by: Wu Quanyang, et al.
Published: (2024)

The American Cancer Society National Lung Cancer Roundtable strategic plan: Challenges in clinical guideline recommendations for biomarker testing in lung cancer
by: Shetal A. Patel, et al.
Published: (2026)

USP22 promotes gefitinib resistance and inhibits ferroptosis in non‐small cell lung cancer by deubiquitination of MDM2
by: Peng Lu, et al.
Published: (2024)

A systematic review of risk prediction model of venous thromboembolism for patients with lung cancer
by: Yan Wang, et al.
Published: (2024)

Evaluation of cfDNA fragmentation characteristics in plasma for the diagnosis of lung cancer: A prospective cohort study
by: Fudong Xu, et al.
Published: (2024)

The American Cancer Society National Lung Cancer Roundtable strategic plan: Advancing comprehensive biomarker testing in non–small cell lung cancer
by: Adam H. Fox, et al.
Published: (2024)

Clinical manifestation and outcome of lung cancer patients with ocular metastasis: 16 case reports and systematic review
by: Yunxin Liu, et al.
Published: (2024)

CBX4/miR‐190 regulatory loop inhibits lung cancer metastasis
by: Jian Wang, et al.
Published: (2024)

Chidamide plus envafolimab as subsequent treatment in advanced non‐small cell lung cancer patients resistant to anti‐PD‐1 therapy: A multicohort, open‐label, phase II trial with biomarker analysis
by: Yaxiong Zhang, et al.
Published: (2024)

Early pembrolizumab clearance as prognostic biomarker for non‐response in patients with advanced non‐small cell lung cancer
by: Fenna de Vries, et al.
Published: (2025)

The association of nutritional and inflammatory biomarkers with overall survival in patients with non‐small‐cell lung cancer treated with immune checkpoint inhibitors
by: I. M. Horstman, et al.
Published: (2024)

Efficacy of first‐line treatment options beyond RET‐TKIs in advanced RET‐rearranged non‐small cell lung cancer: A multi‐center real‐world study
by: Yihui Ge, et al.
Published: (2024)